The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay
Background. The diagnosis of von Willebrand disease is complex due to the heterogeneity of the disease. About eighty percent of von Willebrand disease patients are diagnosed with a quantitative defect of von Willebrand factor (VWF) where fifty percent is due to an increased clearance of von Willebra...
Main Authors: | S. M. Meiring, B. D. P. Setlai, C. Theron, R. Bragg |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/6232091 |
Similar Items
-
Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria.
by: Happy T Phiri, et al.
Published: (2011-01-01) -
von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups
by: Mahat Marianor, et al.
Published: (2015-08-01) -
von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups
by: Mahat Marianor, et al.
Published: (2015-01-01) -
Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases
by: Noritaka Yada, et al.
Published: (2020-07-01) -
A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
by: Lai SW, et al.
Published: (2021-09-01)